Literature DB >> 30830447

Breath metabolome of mice infected with Pseudomonas aeruginosa.

Giorgia Purcaro1,2, Mavra Nasir3, Flavio A Franchina1,4, Christiaan A Rees3, Minara Aliyeva5, Nirav Daphtary5, Matthew J Wargo5, Lennart K A Lundblad6,7, Jane E Hill8,9.   

Abstract

INTRODUCTION: The measurement of specific volatile organic compounds in breath has been proposed as a potential diagnostic for a variety of diseases. The most well-studied bacterial lung infection in the breath field is that caused by Pseudomonas aeruginosa.
OBJECTIVES: To determine a discriminatory core of molecules in the "breath-print" of mice during a lung infection with four strains of P. aeruginosa (PAO1, PA14, PAK, PA7). Furthermore, we attempted to extrapolate a strain-specific "breath-print" signature to investigate the possibility of recapitulating the genetic phylogenetic groups (Stewart et al. Pathog Dis 71(1), 20-25, 2014. https://doi.org/10.1111/2049-632X.12107 ).
METHODS: Breath was collected into a Tedlar bag and shortly after drawn into a thermal desorption tube. The latter was then analyzed into a comprehensive multidimensional gas chromatography coupled with a time-of-flight mass spectrometer. Random forest algorithm was used for selecting the most discriminatory features and creating a prediction model.
RESULTS: Three hundred and one molecules were significantly different between animals infected with P. aeruginosa, and those given a sham infection (PBS) or inoculated with UV-killed P. aeruginosa. Of those, nine metabolites could be used to discriminate between the three groups with an accuracy of 81%. Hierarchical clustering showed that the signature from breath was due to a specific response to live bacteria instead of a generic infection response. Furthermore, we identified ten additional volatile metabolites that could differentiate mice infected with different strains of P. aeruginosa. A phylogram generated from the ten metabolites showed that PAO1 and PA7 were the most distinct group, while PAK and PA14 were interspersed between the former two groups.
CONCLUSIONS: To the best of our knowledge, this is the first study to report on a 'core' murine breath print, as well as, strain level differences between the compounds in breath. We provide identifications (by running commercially available analytical standards) to five breath compounds that are predictive of P. aeruginosa infection.

Entities:  

Keywords:  Breath; Comprehensive gas chromatography-time-of-flight mass spectrometer (GC×GC ToF MS); Pseudomonas aeruginosa; Volatile organic compounds (VOCs)

Year:  2019        PMID: 30830447      PMCID: PMC6537093          DOI: 10.1007/s11306-018-1461-6

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  26 in total

Review 1.  Innovation: Metabolomics: the apogee of the omics trilogy.

Authors:  Gary J Patti; Oscar Yanes; Gary Siuzdak
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

Review 2.  Current breathomics--a review on data pre-processing techniques and machine learning in metabolomics breath analysis.

Authors:  A Smolinska; A-Ch Hauschild; R R R Fijten; J W Dallinga; J Baumbach; F J van Schooten
Journal:  J Breath Res       Date:  2014-04-08       Impact factor: 3.262

Review 3.  Clinical application of volatile organic compound analysis for detecting infectious diseases.

Authors:  Shneh Sethi; Ranjan Nanda; Trinad Chakraborty
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.

Authors:  Philip E Silkoff; Mats Carlson; Trevor Bourke; Rohit Katial; Elisabeth Ogren; Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2004-11       Impact factor: 10.793

5.  How Pseudomonas aeruginosa adapts to various environments: a metabolomic approach.

Authors:  Eliane Frimmersdorf; Sonja Horatzek; Anya Pelnikevich; Lutz Wiehlmann; Dietmar Schomburg
Journal:  Environ Microbiol       Date:  2010-06       Impact factor: 5.491

6.  Towards the use of breath for detecting mycobacterial infection: a case study in a murine model.

Authors:  Flavio A Franchina; Theodore R Mellors; Minara Aliyeva; Jeff Wagner; Nirav Daphtary; Lennart K A Lundblad; Sarah M Fortune; Eric J Rubin; Jane E Hill
Journal:  J Breath Res       Date:  2018-02-07       Impact factor: 3.262

7.  Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study).

Authors:  Michael Phillips; John P Boehmer; Renee N Cataneo; Taseer Cheema; Howard J Eisen; John T Fallon; Peter E Fisher; Alan Gass; Joel Greenberg; Jon Kobashigawa; Donna Mancini; Barry Rayburn; Mark J Zucker
Journal:  J Heart Lung Transplant       Date:  2004-06       Impact factor: 10.247

8.  Increased nitric oxide in exhaled air of asthmatic patients.

Authors:  S A Kharitonov; D Yates; R A Robbins; R Logan-Sinclair; E A Shinebourne; P J Barnes
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

Review 9.  Assessment, origin, and implementation of breath volatile cancer markers.

Authors:  Hossam Haick; Yoav Y Broza; Pawel Mochalski; Vera Ruzsanyi; Anton Amann
Journal:  Chem Soc Rev       Date:  2013-12-04       Impact factor: 54.564

10.  Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.

Authors:  Mavra Nasir; Heather D Bean; Agnieszka Smolinska; Christiaan A Rees; Edith T Zemanick; Jane E Hill
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

View more
  1 in total

Review 1.  Breath-Based Diagnosis of Infectious Diseases: A Review of the Current Landscape.

Authors:  Chiranjit Ghosh; Armando Leon; Seena Koshy; Obadah Aloum; Yazan Al-Jabawi; Nour Ismail; Zoe Freeman Weiss; Sophia Koo
Journal:  Clin Lab Med       Date:  2021-06       Impact factor: 2.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.